We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ConserV

News List

ConserV Bio partners with eTheRNA on mRNA vaccine development pharmatimes
March 05, 2021
London, UK-based ConserV Bioscience has teamed up with eTheRNA immunotherapies to develop mRNA-based vaccines for infectious diseases.
ConserV Bioscience, LLNL to Collaborate on Development of Broad-spectrum Coronavirus Vaccine americanpharmaceuticalreview
January 25, 2021
ConserV Bioscience Limited and Lawrence Livermore National Laboratory (LLNL) have agreed to collaborate on the development of a broad-spectrum coronavirus vaccine.
ConserV Bioscience to develop ‘broad-spectrum’ coronavirus vaccine pharmatimes
January 21, 2021
UK biotech company ConserV Bioscience will collaborate on the development of a broad-spectrum coronavirus vaccine with Lawrence Livermore National Laboratory (LLNL).